Despite 19% Profit Surge, Swiss Re Stock Stalls as Analysts Maintain Sell Ratings

Despite a 19% profit jump to $1.5B and ambitious full-year targets, Swiss Re shares trade near 52-week lows as analysts issue sell ratings and leadership changes add uncertainty.

Swiss Re has posted a blockbuster first quarter, but the market is refusing to buy the story. The Zurich-based reinsurer reported a net profit of $1.5 billion for the period — a 19% jump from a year earlier — while booking an IFRS return on equity of 23.6%. Lower catastrophe losses and a robust investment result powered the gains. Yet the share price tells a different tale: at €128.90 on June 5, the stock stands just 4.2% above its 52-week low and remains more than 11% below its 200-day moving average. Year to date, the decline exceeds 10%.

A leadership overhaul underway at the company adds further uncertainty. On June 1, Suzanne Revell took charge of the global marine and energy portfolio within P&C Re, succeeding Adam Watkins and based in London. Daniel Neo was also appointed to the board of Swiss Re Asia, bringing over two decades of C-suite experience and regional know-how. Then on July 1, Trent Thomson — currently CEO for Australia and New Zealand — will relocate to London to become Head of Global Specialty, replacing Anne Lohbeck, who moves up to Chief Risk Officer for P&C Re.

The timing of these moves is deliberate. Chief Executive Andreas Berger expects the mid-year renewal season to extend the same trends seen earlier in 2026: strong demand but persistent price pressure. Abundant capital in the market has intensified competition, especially in non-proportional natural catastrophe lines, and specialty rates have continued to soften. Berger has made clear that portfolio quality will trump volume, a stance that is being tested as exposures in climate, cyber and liability become more complex.

For the full year, Swiss Re has set ambitious targets: a net profit of $4.5 billion, an IFRS return on equity above 14%, annual dividend growth of at least 7% through 2027, and $500 million per year in share buybacks. The first-quarter results gave those goals credibility, but the stock's weakness suggests investors are focusing on the headwinds rather than the headline numbers.

That wariness is reinforced by the analyst community. A market overview compiled in early June summarizes ten analyst ratings for May, with the majority falling into "sell" territory. UBS issued a target of €112 on June 2 with a "Sell" rating. Autonomous followed on June 1 with a €120 target and "Underperform", while Barclays Capital set €113 and "Underweight" on the same date. Keefe, Bruyette & Woods also came in at €120 with an "Underperform" on June 1. All of these targets sit well below the current share price, creating a ceiling on any rally.

There are bright spots, however. Vontobel rates the stock a "Buy" with a €140 target as of May 19, while DZ Bank and Octavian are even more bullish, setting targets of €160 and €164 respectively on May 7. This wide dispersion — ranging from €112 to €164 — explains why the stock has not been written off entirely. Some analysts see meaningful upside, while others view the recent slide as validation of their cautious stance.

For now, the market is in a holding pattern. The next major catalyst comes on August 6, when Swiss Re releases its first-half results. Until then, the stock remains trapped between strong operating momentum and a bearish consensus that questions the sustainability of those earnings. How the new leadership team performs during the mid-year renewals could tip the balance one way or the other.